Virtus ETF Advisers’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,278
| Closed | -$69.8K | – | 618 |
|
|
2024
Q4 | $69.8K | Buy |
5,278
+827
| +19% | +$10.9K | 0.03% | 379 |
|
|
2024
Q3 | $85.7K | Buy |
4,451
+78
| +2% | +$1.5K | 0.04% | 403 |
|
|
2024
Q2 | $89.8K | Buy |
4,373
+14
| +0.3% | +$287 | 0.04% | 359 |
|
|
2024
Q1 | $104K | Sell |
4,359
-298
| -6% | -$7.09K | 0.06% | 357 |
|
|
2023
Q4 | $101K | Buy |
4,657
+125
| +3% | +$2.7K | 0.06% | 355 |
|
|
2023
Q3 | $65.8K | Sell |
4,532
-451
| -9% | -$6.55K | 0.04% | 395 |
|
|
2023
Q2 | $104K | Buy |
4,983
+863
| +21% | +$18.1K | 0.06% | 361 |
|
|
2023
Q1 | $87K | Sell |
4,120
-1,581
| -28% | -$33.4K | 0.05% | 369 |
|
|
2022
Q4 | $145K | Sell |
5,701
-927
| -14% | -$23.6K | 0.08% | 355 |
|
|
2022
Q3 | $159K | Buy |
6,628
+44
| +0.7% | +$1.06K | 0.06% | 345 |
|
|
2022
Q2 | $127K | Sell |
6,584
-2,139
| -25% | -$41.3K | 0.05% | 366 |
|
|
2022
Q1 | $152K | Sell |
8,723
-515
| -6% | -$8.97K | 0.07% | 226 |
|
|
2021
Q4 | $202K | Sell |
9,238
-2,003
| -18% | -$43.8K | 0.08% | 205 |
|
|
2021
Q3 | $215K | Sell |
11,241
-594
| -5% | -$11.4K | 0.09% | 251 |
|
|
2021
Q2 | $203K | Buy |
11,835
+7
| +0.1% | +$120 | 0.08% | 336 |
|
|
2021
Q1 | $264K | Buy |
11,828
+204
| +2% | +$4.55K | 0.11% | 273 |
|
|
2020
Q4 | $259K | Sell |
11,624
-8,270
| -42% | -$184K | 0.11% | 300 |
|
|
2020
Q3 | $294K | Sell |
19,894
-2,702
| -12% | -$39.9K | 0.15% | 230 |
|
|
2020
Q2 | $335K | Buy |
+22,596
| New | +$335K | 0.16% | 278 |
|